Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Helena Norberg

Helena Norberg

Jag forskar om följsamhet, kliniska apotekares roll i vården samt hur nya terapier kan introduceras mer systematiskt. Jag undervisar inom farmaciprogrammen.

Kontakt

E-post
helena.norberg@umu.se
Telefon
090-786 68 21

Verksam vid

Anknytning
Postdoktor vid Institutionen för integrativ medicinsk biologi (IMB)
Plats
hus H, Johan Bures väg 12, Biologihuset Umeå universitet, 901 87 Umeå
Anknytning
Universitetsadjunkt (tjänstledig) vid Institutionen för integrativ medicinsk biologi (IMB)
Plats
hus H, Johan Bures väg 12, Biologihuset Umeå universitet, 901 87 Umeå
Anknytning
Anknuten som övrig/annan befattning till Institutionen för folkhälsa och klinisk medicin Enhet: Avdelningen för medicin
Plats
1A, målpunkt B41, plan 4, Norrlands universitetssjukhus Umeå universitet, by1a, B41, NUS, 901 85 Umeå
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study
European Journal of Clinical Pharmacology, Springer 2021, Vol. 77 : 125-131
Norberg, Helena; Bergdahl, Ellinor; Hellström Ängerud, Karin; et al.
Comparison of creatinine-based methods for estimating glomerular filtration rate in patients with heart failure
ESC Heart Failure, John Wiley & Sons 2020, Vol. 7, (3) : 1150-1160
Jonsson, Anna; Viklund, Ida; Jonsson, Andreas; et al.
Bridging the gap between clinical trials and clinical practice: sacubitril-valsartan in heart failure as a model
Umeå University medical dissertations, 2096
Norberg, Helena
Ny metod för regional implementering av nya behandlingar vid kronisk sjukdom
Läkartidningen, Läkartidningen Förlag 2020, Vol. 117, (46-47) : 1518-1518
Norberg, Helena
Differences in medical treatment and clinical characteristics between men and women with heart failure: a single-centre multivariable analysis
European Journal of Clinical Pharmacology, Springer 2020, Vol. 76, (4) : 539-546
Norberg, Helena; Pranic, Veronica; Bergdahl, Ellinor; et al.
Clinical trial enrolment favours men: Fewer women meet eligibility criteria for trials of heart failure medication is discussed by Helena Norberg from Sweden
European Heart Journal, OXFORD UNIV PRESS 2019, Vol. 40, (14) : 1104-1105
Norberg, Helena
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
Cardiovascular Therapeutics, Vol. 2019
Norberg, Helena; Bergdahl, Ellinor; Lindmark, Krister
Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure population
Cardiovascular therapeutics, John Wiley & Sons 2018, Vol. 36, (5)
Jonsson, Anna; Norberg, Helena; Bergdahl, Ellinor; et al.
Who enrols and graduates from web-based pharmacy education: experiences from Northern Sweden
Currents in pharmacy teaching and learning, Elsevier 2018, Vol. 10, (8) : 1004-1012
Mattsson, Sofia; Gustafsson, Maria; Svahn, Sofia; et al.
Eligibility of sacubitril–valsartan in a real-world heart failure population: a community-based single-centre study
ESC Heart Failure, John Wiley & Sons 2018, Vol. 5, (2) : 337-343
Norberg, Helena; Bergdahl, Ellinor; Lindmark, Krister
Visa publikationer i DiVA